Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-VEC with Preoperative Radiation in Soft Tissue Sarcoma
NCT02453191Phase 2Completed
- Sponsor
- University of Iowa
- Start
- Jul 2015
- Primary completion
- Jan 2019
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of talimogene laherparepvec in soft tissue sarcoma (STS), sponsored by University of Iowa. Started Jul 2015; status: completed.
02
Drugs
talimogene laherparepvec
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT02453191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02453191.